Biological markers in alcoholism.

Area of Science:

• Biochemistry
• Clinical Chemistry
• Toxicology

Background:

• Alcohol biomarkers are crucial for assessing alcohol consumption patterns.
• Distinguishing between state markers (acute/chronic intake) and trait markers (genetic predisposition) is key.
• Current methods vary in sensitivity and specificity for detecting alcohol use.

Purpose of the Study:

• To review the utility of various alcohol biomarkers in clinical practice.
• To highlight the strengths and limitations of different markers for monitoring alcohol intake and abstinence.
• To emphasize the role of biomarkers in understanding drinking patterns and evaluating treatment outcomes.

Main Methods:

• Review of existing literature on alcohol biomarker assays.
• Discussion of established markers such as ethanol, 5-hydroxytryptophol, ethyl glucuronide, liver function tests (GGT, AST, ALT), mean corpuscular volume (MCV), and carbohydrate-deficient transferrin (CDT).
• Analysis of marker sensitivity, specificity, and clinical applications for detecting recent and chronic alcohol consumption.

Main Results:

• Ethanol detection is limited to very recent alcohol intake.
• Urinary 5-hydroxytryptophol and ethyl glucuronide provide more sensitive detection of recent drinking.
• Liver function tests and MCV have low specificity for alcohol, while CDT shows higher specificity for excessive consumption and abstinence monitoring.

Conclusions:

• Alcohol biomarkers are valuable for objective evaluation of drinking patterns and treatment efficacy.
• Specific markers like CDT are effective for monitoring abstinence in outpatient treatment.
• Biomarkers aid in the early identification of at-risk drinking and relapse detection.